Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

PURPOSE: We evaluated the clinical responses and radiographic outcomes of 90 patients with rheumatoid arthritis (RA) undergoing continuous or dose-adjusted infliximab treatment over 104 weeks. PATIENTS AND METHODS: Patients received 3 mg/kg infliximab continuously (the contin group; n=50), or the do...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozaki, Yuji, Nagare, Yasuaki, Ashida, Chisato, Tomita, Daisuke, Okada, Akinori, Inoue, Asuka, Kinoshita, Koji, Funauchi, Masanori, Matsumura, Itaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267494/
https://www.ncbi.nlm.nih.gov/pubmed/30568425
http://dx.doi.org/10.2147/BTT.S187998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267494/
https://www.ncbi.nlm.nih.gov/pubmed/30568425
http://dx.doi.org/10.2147/BTT.S187998

Ejemplares similares